Effects of interleukin-6 ablation on fracture healing in mice

Journal of Orthopaedic Research

Volumn 29, Issue 9, 2011, Pages 1437-1442

  Wallace, Aaron ^a   Cooney, Timothy E ^b,c   Englund, Richard ^b   Lubahn, John D ^c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b HAMOT MEDICAL CENTER   (United States)

^c BEHREND COLLEGE   (United States)

Author keywords

cytokines; fracture healing; interleukin 6

Indexed keywords

ALKALINE PHOSPHATASE; INTERLEUKIN 6; OSTEOCALCIN; TARTARIC ACID DERIVATIVE; TARTRATE RESISTANT ALKALINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BONE STRENGTH; CALLUS; CELL COUNT; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FRACTURE HEALING; HISTOPATHOLOGY; KNOCKOUT MOUSE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TIBIA FRACTURE; WILD TYPE;

ACID PHOSPHATASE; ANIMALS; BONY CALLUS; DISEASE MODELS, ANIMAL; ELASTICITY; FRACTURE HEALING; INTERLEUKIN-6; ISOENZYMES; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCALCIN; STRESS, MECHANICAL; TIBIAL FRACTURES;

EID: 79960233326     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21367     Document Type: Article

References (40)

1. Askalonov AA, Gordienko SM, Avdyunicheva OE, et al. 1987. The role of T-system immunity in reparatory regeneration of the bone tissue in animals. J Hyg Epidemiol Microbiol Immunol 31: 219-224.
2. Henricson A, Hulth A, Johnell O,. 1991. The occurrence of accessory immunologic cells in bone induction. Clin Orthop 260: 270-277.
3. Andrew JG, Andrew SM, Freemont AJ, et al. 1994. Inflammatory cells in normal human fracture healing. Acta Orthop Scand 65: 462-466. (Pubitemid 24331059)
4. Chung R, Cool JC, Scherer MA, et al. 2006. Roles of neutrophil-mediated inflammatory response in bony repair of injured growth plate cartilage in young rats. J Leukocyte Biol 80: 1272-1280. (Pubitemid 44904966)
5. Einhorn TA, Majeska RJ, Rush EB, et al. 1995. The expression of cytokine activity by fracture callus. J Bone Miner Res 10: 1272-1281.
6. Kon T, Cho TJ, Aizawa T, et al. 2001. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16: 1004-1014. (Pubitemid 32467144)
7. Frost A, Jonsson KB, Nilsson O, et al. 1997. Inflammatory cytokines regulate proliferation of cultured human osteoblasts. Acta Orthop Scand 68: 91-96. (Pubitemid 27202065)
8. Morioka M, Shimodaira K, Kuwano Y, et al. 2000. Effect of interleukin-1beta on aromatase activity and cell proliferation in human osteoblast-like cells (HOS). Biochem Biophys Res Commun 268: 60-64. (Pubitemid 30116610)
9. Rickard DJ, Gowen M, MacDonald BR,. 1993. Proliferative responses to estradiol, IL-1 alpha and TGF beta by cells expressing alkaline phosphatase in human osteoblast-like cell cultures. Calcif Tissue Int 52: 227-233. (Pubitemid 23090717)
10. Olmedo ML, Landry PS, Sadasivan KK, et al. 1999. Regulation of osteoblast levels during bone healing. J Orthop Trauma 13: 356-362.
11. Olmedo ML, Landry PS, Sadasivan KK, et al. 2000. Programmed cell death in post-traumatic bone callus. Cell Mol Biol 46: 89-97.
12. Linkhart TA, Linkhart SG, MacCharles DC, et al. 1991. Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin. J Bone Miner Res 6: 1285-1294.
13. Hierl T, Borcsok I, Sommer U, et al. 1998. Regulation of interleukin-6 expression in human osteoblastic cells in vitro. Exp Clin Endocrinol Diabetes 106: 324-333. (Pubitemid 28457014)
14. Johnson CS, Jerome CP, Brommage R,. 2000. Unbiased determination of cytokine localization in bone: colocalization of interleukin-6 with osteoblasts in serial sections from monkey vertebrae. Bone 26: 461-467. (Pubitemid 30204466)
15. Tanaka Y, Nakayamada S, Okada Y,. 2005. Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy 4: 325-328. (Pubitemid 40873119)
16. Itoh S, Udagawa N, Takahashi N, et al. 2006. A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone 39: 505-512. (Pubitemid 44149269)
17. Li Y, Backesjo CM, Haldosen LA, et al. 2008. IL-6 receptor expression and IL-6 effects change during osteoblast differentiation. Cytokine 43: 165-173.
18. Bellido T, Borba VZC, Roberson P, et al. 1997. Activation of the Janus Kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinol 138: 3666-3676. (Pubitemid 27351915)
19. Hughes FJ, Howells GL,. 1993. Interleukin-6 inhibits bone formation in vitro. Bone Miner 21: 21-28. (Pubitemid 23161155)
20. Chae HJ, Ha KC, Lee GY, et al. 2007. Interleukin-6 and cyclic AMP stimulate release of cathepsin B in human osteoblasts. Immunopharmacol Immunotoxicol 29: 155-172.
21. Cho T-J, Kim JA, Chung CY, et al. 2007. Expression and role of interleukin-6 in distraction osteogenesis. Calcif Tissue Int 80: 192-200. (Pubitemid 46411882)
22. Kuroda S, Virdi AS, Dai Y, et al. 2005. Patterns and localization of gene expression during intramembranous bone regeneration in the rat femoral marrow ablation model. Calcif Tissue Int 77: 212-215.
23. Gerstenfeld LC, Culliane DM, Barnes GL, et al. 2003. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88: 873-884. (Pubitemid 36337032)
24. Yang X, Ricciardi BF, Hernandez-Soria A, et al. 2007. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 41: 928-936. (Pubitemid 350116738)
25. Axmann R, Bohm C, Kronke G, et al. 2009. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum 60: 2747-2756.
26. Gerstenfeld LC, Thiede M, Seibert K, et al. 2003. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 21: 670-675. (Pubitemid 36763489)
27. Simon AM, Manigrasso MB, O'Connor JP,. 2002. Cyclo-oxygenase 2 function is essential for bone fracture healing [see comment]. J Bone Miner Res 17: 963-976. (Pubitemid 34535133)
28. Zhang X, Schwarz EM, Young DA, et al. 2002. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109: 1405-1415. (Pubitemid 34596166)
29. Bergenstock M, Min W, Simon AM, et al. 2005. A comparison between the effects of acetaminophen and celecoxib on bone fracture healing in rats. J Orthop Trauma 19: 717-723. (Pubitemid 44378210)
30. Meunier A, Aspenberg P,. 2006. Parecoxib impairs early metaphyseal bone healing in rats. Arch Orthop Trauma Surg 126: 433-436. (Pubitemid 44194505)
31. Gregory LS, Forwood MR,. 2007. Cyclooxygenase-2 inhibition delays the attainment of peak woven bone formation following four-point bending in the rat. Calcif Tissue Int 80: 176-183. (Pubitemid 46411879)
32. Herbenick MA, Sprott D, Stills H, et al. 2008. Effects of a cyclooxygenase 2 inhibitor on fracture healing in a rat model. Am J Orthop 37: E133-E137.
33. Huo MH, Troiano NW, Pelker RR, et al. 1991. The influence of ibuprofen on fracture repair: biomechanical, biochemical, histologic, and histomorphometric parameters. J Orthop Res 9: 383-390.
34. Duplomb L, Baud'huin M, Charrier C, et al. 2008. Interleukin-6 inhibits receptor activator of nuclear factor κβ ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine 727 phosphorylation of signal transducer and activator of transcription 3. Endocrinol 149: 688-697.
35. Yoshatake F, Itoh S, Narita H, et al. 2008. Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-κβ signaling pathways. J Biol Chem 283: 11535-11540.
36. Nakamura A, Dohi Y, Akahane M, et al. 2009. Osteocalcin secretion as an early marker of in vitro osteogenic differentiation of rat mesenchymal stem cells. Tissue Eng Part C Methods 15: 169-180.
37. Littlewood AJ, Aarden LA, Evans DB, et al. 1991. Human osteoblast like cells do not respond to interleukin-6. J Bone Miner Res 6: 141-148.
38. Nishimura R, Moriyama K, Yasukawa K, et al. 1998. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblast cells. J Bone Miner Res 13: 777-785. (Pubitemid 28224193)
39. Motomura T, Kasayama S, Takagi M, et al. 1998. Increased interleukin-6 production in mouse osteoblastic MC3T3-E1 cells expressing activating mutant of the stimulatory G protein. J Bone Miner Res 13: 1084-1091. (Pubitemid 28311776)
40. Flick LM, Weaver JM, Ulrich-Vinther M, et al. 2003. Effects of receptor activator of NFκβ (RANK) signaling blockade on fracture healing. J Orthop Res 21: 676-684. (Pubitemid 36758211)